7/1, 3:05 PM (Source: TeleTrader)
more TeleTrader news

Pfizer, BioNTech COVID-19 vaccine trial successful

The Pfizer and BioNTech COVID-19 vaccine showed positive results as it created antibodies against the SARS-CoV-2 virus, a paper on MedRXiv revealed on Wednesday. The preliminary study also showed that patients that received the vaccine had between 1.8 and 2.8 times the level of antibodies against the virus compared to people who had the disease and recovered.

However, the trial for the RNA vaccine was limited to 45 people and Pfizer will need to conduct larger tests to find out how successful the vaccine really is.

BioNTech shares were halted in premarket after the report as they surged 7.39%. Pfizer jumped 6.61% shortly before trading started on Wall Street.

Breaking the News / VP